These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Partial compliance with antipsychotics and its impact on patient outcomes. Narasimhan M; Un Pae C; Masand N; Masand P Int J Psychiatry Clin Pract; 2007; 11(2):102-11. PubMed ID: 24937555 [TBL] [Abstract][Full Text] [Related]
65. Partial compliance in schizophrenia and the impact on patient outcomes. Llorca PM Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080 [TBL] [Abstract][Full Text] [Related]
66. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based]. Schanda H; Stompe T Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916 [TBL] [Abstract][Full Text] [Related]
67. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Bhanji NH; Chouinard G; Margolese HC Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023 [TBL] [Abstract][Full Text] [Related]
68. The case for long-acting antipsychotic agents in the post-CATIE era. Nasrallah HA Acta Psychiatr Scand; 2007 Apr; 115(4):260-7. PubMed ID: 17355516 [TBL] [Abstract][Full Text] [Related]
69. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS; Stewart DW J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985 [TBL] [Abstract][Full Text] [Related]
70. Medication adherence and the use of long-acting antipsychotics in bipolar disorder. El-Mallakh RS J Psychiatr Pract; 2007 Mar; 13(2):79-85. PubMed ID: 17414683 [TBL] [Abstract][Full Text] [Related]
71. Influences on therapist's decisions for neuroleptic treatment in schizophrenia: the role of characteristics of the patient and the physician. Franz M; Ranger J; Hanewald B; Gallhofer B; Lay B Pharmacopsychiatry; 2012 Nov; 45(7):261-8. PubMed ID: 22648306 [TBL] [Abstract][Full Text] [Related]
72. A review of second-generation antipsychotic discontinuation in first-episode psychosis. Miller BJ J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960 [TBL] [Abstract][Full Text] [Related]
73. Pharmacological prevention of relapse. Lader M Kaohsiung J Med Sci; 1998 Jul; 14(7):448-57. PubMed ID: 9739577 [TBL] [Abstract][Full Text] [Related]